Found: 30
Select item for more details and to access through your institution.
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Nutrients, 2020, v. 12, n. 4, p. 1021, doi. 10.3390/nu12041021
- By:
- Publication type:
- Article
Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 13, p. 10885, doi. 10.3390/ijms241310885
- By:
- Publication type:
- Article
Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia.
- Published in:
- European Journal of Endocrinology, 2003, v. 148, n. 3, p. 325, doi. 10.1530/eje.0.1480325
- By:
- Publication type:
- Article
Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine.
- Published in:
- European Journal of Endocrinology, 1998, v. 138, n. 3, p. 286, doi. 10.1530/eje.0.1380286
- By:
- Publication type:
- Article
Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 10, p. 3777, doi. 10.1210/jc.2007-1403
- By:
- Publication type:
- Article
Prolactin and Prostate Hypertrophy: A Pilot Observational, Prospective, Case-Control Study in Men with Prolactinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2004, v. 89, n. 6, p. 2770, doi. 10.1210/jc.2003-032055
- By:
- Publication type:
- Article
Resistance to Cabergoline as Compared with Bromocriptine in Hyperprolactinemia: Prevalence, Clinical Definition, and Therapeutic Strategy.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 11, p. 5256, doi. 10.1210/jcem.86.11.8054
- By:
- Publication type:
- Article
Effect of Two Years of Growth Hormone and Insulin-Like Growth Factor-I Suppression on Prostate Diseases in Acromegalic Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 10, p. 3754, doi. 10.1210/jcem.85.10.6907
- By:
- Publication type:
- Article
Macroprolactinoma Shrinkage during Cabergoline Treatment Is Greater in Naive Patients Than in Patients Pretreated with Other Dopamine Agonists: A Prospective Study in 110 Patients.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2000, v. 85, n. 6, p. 2247, doi. 10.1210/jcem.85.6.6657
- By:
- Publication type:
- Article
Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic Males.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 3, p. 807, doi. 10.1210/jcem.83.3.4674
- By:
- Publication type:
- Article
Prostatic Hyperplasia: An Unknown Feature of Acromegaly.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1998, v. 83, n. 3, p. 775, doi. 10.1210/jcem.83.3.4645
- By:
- Publication type:
- Article
Prolactinomas Resistant to Standard Dopamine Agonists Respond to Chronic Cabergoline Treatment.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 3, p. 876, doi. 10.1210/jcem.82.3.3822
- By:
- Publication type:
- Article
Effect of Different Dopaminergic Agents in the Treatment of Acromegaly.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 2, p. 518, doi. 10.1210/jcem.82.2.3648
- By:
- Publication type:
- Article
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons.
- Published in:
- Endocrine (1355008X), 2024, v. 85, n. 2, p. 520, doi. 10.1007/s12020-024-03767-7
- By:
- Publication type:
- Article
Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group.
- Published in:
- Endocrine (1355008X), 2019, v. 66, n. 2, p. 417, doi. 10.1007/s12020-019-01894-0
- By:
- Publication type:
- Article
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
- Published in:
- Endocrine (1355008X), 2014, v. 47, n. 1, p. 177, doi. 10.1007/s12020-013-0130-9
- By:
- Publication type:
- Article
Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.
- Published in:
- Clinical Endocrinology, 2007, v. 67, n. 3, p. 426, doi. 10.1111/j.1365-2265.2007.02905.x
- By:
- Publication type:
- Article
The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males.
- Published in:
- Clinical Endocrinology, 2006, v. 64, n. 3, p. 307, doi. 10.1111/j.1365-2265.2006.02461.x
- By:
- Publication type:
- Article
Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood-onset and adulthood-onset disease.
- Published in:
- Clinical Endocrinology, 2002, v. 56, n. 2, p. 153, doi. 10.1046/j.0300-0664.2001.01454.doc.x
- By:
- Publication type:
- Article
Central diabetes insipidus and heart: effect of acute arginine vasopressin deficiency and replacement treatment with desmopressin on cardiac performance.
- Published in:
- Clinical Endocrinology, 2001, v. 54, n. 1, p. 97, doi. 10.1046/j.1365-2265.2001.01207.x
- By:
- Publication type:
- Article
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
- Published in:
- Clinical Endocrinology, 2000, v. 53, n. 1, p. 53, doi. 10.1046/j.1365-2265.2000.01016.x
- By:
- Publication type:
- Article
Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with [sup 123]I-methoxybenzamide.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 4, p. 437, doi. 10.1046/j.1365-2265.2000.00951.x
- By:
- Publication type:
- Article
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.
- Published in:
- Clinical Endocrinology, 2000, v. 52, n. 3, p. 319, doi. 10.1046/j.1365-2265.2000.00902.x
- By:
- Publication type:
- Article
Osteoporosis and dermatoporosis: a review on the role of vitamin D.
- Published in:
- Frontiers in Endocrinology, 2023, p. 1, doi. 10.3389/fendo.2023.1231580
- By:
- Publication type:
- Article
Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2422, doi. 10.3390/cancers12092422
- By:
- Publication type:
- Article
Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1332, doi. 10.3390/cancers11091332
- By:
- Publication type:
- Article
Treatment of Hydatid Liver Cyst With Double Percutaneous Aspiration and Ethanol Injection Under Ultrasound Guidance: 6.5-Year Median Follow-up Analysis.
- Published in:
- CardioVascular & Interventional Radiology, 2021, v. 44, n. 8, p. 1214, doi. 10.1007/s00270-021-02839-9
- By:
- Publication type:
- Article
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1224, doi. 10.3390/jcm8081224
- By:
- Publication type:
- Article
Hepatic arterial embolization in patients with neuroendocrine tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2014, v. 33, n. 1, p. 1, doi. 10.1186/1756-9966-33-43
- By:
- Publication type:
- Article